Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry

Roberto Rordorf, Fernando Scazzuso, Kyoung Ryul Julian Chun, Surinder Kaur Khelae, Fred J. Kueffer, Kendra M. Braegelmann, Ken Okumura, Fawzia Al-Kandari, Young Keun On, Csaba Földesi

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

BACKGROUND: Heart failure (HF) and atrial fibrillation (AF) often coexist; yet, outcomes of ablation in patients with AF and concomitant HF are limited. This analysis assessed outcomes of cryoablation in patients with AF and HF. METHODS AND RESULTS: The Cryo AF Global Registr y is a prospective, multicenter registr y of patients with AF who were treated with cryoballoon ablation according to routine practice at 56 sites in 26 countries. Patients with baseline New York Heart Association class I to III (HF cohort) were compared with patients without HF. Freedom from atrial arrhyth-mia recurrence ≥30 seconds, safety, and health care utilization over 12-month follow-up were analyzed. A total of 1303 patients (318 HF) were included. Patients with HF commonly had preser ved lef t ventricular ejection fraction (81.6%), were more of ten women (45.6% versus 33.6%) with persistent AF (25.8% versus 14.3%), and had a larger lef t atrial diameter (4.4±0.9 versus 4.0±0.7 cm). Serious procedure-related complications occurred in 4.1% of patients with HF and 2.6% of patients without HF (P=0.188). Freedom from atrial arrhythmia recurrence was not dif ferent between cohorts with either paroxysmal AF (84.2% [95% CI, 78.6– 88.4] versus 86.8% [95% CI, 84.2– 89.0]) or persistent AF (69.6% [95% CI, 58.1– 78.5] versus 71.8% [95% CI, 63.2– 78.7]) (P=0.319). Af ter ablation, a reduction in AF-related symptoms and antiarrhythmic drug use was observed in both cohorts (HF and no-HF), and freedom from repeat ablation was not dif ferent between cohorts. Persistent AF and HF predicted a post-ablation cardiovascular rehospitalization (P=0.032 and P=0.001, respecti vel y). CONCLUSIONS: Cryoablation to treat patients with AF is similarly effective at 12 months in patients with and without HF. REGISTRATION: URL: https://www.clini​caltr​ials.gov; Unique Identifier: NCT02752737.

Original languageEnglish
Article numbere021323
JournalJournal of the American Heart Association
Volume10
Issue number24
DOIs
StatePublished - 21 Dec 2021
Externally publishedYes

Keywords

  • Atrial fibrillation
  • Catheter ablation
  • Heart failure

Fingerprint

Dive into the research topics of 'Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry'. Together they form a unique fingerprint.

Cite this